Celeste E. Poteet-Smith
Impact in
- Endocrinology top 5%
- Escherichia coli research studies
- Molecular Biology top 10%
- Melanoma and MAPK Pathways
- Protein Kinase Regulation and GTPase Signaling
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- Melanoma and MAPK Pathways 5
- PI3K/AKT/mTOR signaling in cancer 2
- Ion channel regulation and function 1
- Phosphodiesterase function and regulation 1
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Jeffrey A. Smith (4 shared papers)Thomas W. Sturgill (4 shared papers)Kevin Malarkey (1 shared paper)Deborah A. Lannigan (4 shared papers)Sidney M. Hecht (1 shared paper)Ya-Ming Xu (1 shared paper)Timothy M. Errington (1 shared paper)Richard L. Guerrant (1 shared paper)
- Journals
- Journal of Biological Chemistry (5 papers)Molecular and Cellular Biology (1 paper)Cancer Research (1 paper)Journal of Clinical Investigation (1 paper)PubMed (1 paper)
- Partner nations
- United StatesNorwayBelgium
In The Last Decade
Celeste E. Poteet-Smith
9 papers receiving 892 citations
Peers
Comparison fields: 5 of 74
- Endocrinology 116
- Molecular Biology 648
- Cell Biology 95
- Oncology 128
- Immunology 100
Countries citing papers authored by Celeste E. Poteet-Smith
This map shows the geographic impact of Celeste E. Poteet-Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celeste E. Poteet-Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celeste E. Poteet-Smith more than expected).
Fields of papers citing papers by Celeste E. Poteet-Smith
This network shows the impact of papers produced by Celeste E. Poteet-Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celeste E. Poteet-Smith. The network helps show where Celeste E. Poteet-Smith may publish in the future.
Co-authors
The 21 scholars most cited alongside Celeste E. Poteet-Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 248 | |
| 2 | 2005 | 246 | |
| 3 | 2000 | 199 | |
| 4 | 1997 | 76 | |
| 5 | 1999 | 61 | |
| 6 | 2000 | 37 | |
| 7 | 1997 | 30 | |
| 8 | 1997 | 7 | |
| 9 | 1999 | 1 |
About Celeste E. Poteet-Smith
Celeste E. Poteet-Smith is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Infectious Diseases and Ecology, Evolution, Behavior and Systematics, having authored 9 papers that have together received 905 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Cancer Mechanisms and Therapy (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Ion channel regulation and function (1 paper), Phosphodiesterase function and regulation (1 paper), Amino Acid Enzymes and Metabolism (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Endocrinology (116 citations), Molecular Biology (648 citations), Cell Biology (95 citations), Oncology (128 citations) and Immunology (100 citations). Celeste E. Poteet-Smith has collaborated with scholars based in United States, Norway and Belgium. Frequent co-authors include Jeffrey A. Smith, Thomas W. Sturgill, Kevin Malarkey, Deborah A. Lannigan, Sidney M. Hecht, Ya-Ming Xu, Timothy M. Errington, Richard L. Guerrant, James P. Nataro and Jeffrey A. Smith. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, Cancer Research, Journal of Clinical Investigation and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.